(Q43824418)

27 November 2017

title

Patient-reported quality of life during radiation treatment for localized prostate cancer: results from a prospective phase II trial (English)

1 reference

27 November 2017

main subject

phase II clinical trial

0 references

1 reference

Ronald C Chen

1

1 reference

27 November 2017

Yuanye Zhang

2

1 reference

27 November 2017

Ming-Hui Chen

3

1 reference

27 November 2017

Elizabeth McMahon

4

1 reference

27 November 2017

Marian Loffredo

5

1 reference

27 November 2017

Carol P McPherson

6

1 reference

27 November 2017

Angela U Nguyen

7

1 reference

27 November 2017

Paul L Nguyen

8

1 reference

27 November 2017

Anthony V D'Amico

9

1 reference

27 November 2017

publication date

13 April 2012

1 reference

27 November 2017

1 reference

27 November 2017

volume

110

1 reference

27 November 2017

issue

11

1 reference

27 November 2017

page(s)

1690-1695

1 reference

Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute-sponsored clinical trials networks

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11117.X

Patient-reported outcomes in phase II cancer clinical trials: lessons learned and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11117.X

Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11117.X

Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11117.X

An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11117.X

Acute side effects during 3-D-planned conformal radiotherapy of prostate cancer. Differences between patient's self-reported questionnaire and the corresponding doctor's report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11117.X

Randomized trials with quality of life endpoints: are doctors' ratings of patients' physical symptoms interchangeable with patients' self-ratings?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11117.X

Patient-reported outcomes assessment in cancer trials: evaluating and enhancing the payoff to decision making.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11117.X

Impact on rectal dose from the use of a prostate immobilization and rectal localization device for patients receiving dose escalated 3D conformal radiation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11117.X

Acute gastrointestinal, genitourinary, and dermatological toxicity during dose-escalated 3D-conformal radiation therapy (3DCRT) using an intrarectal balloon for prostate gland localization and immobilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11117.X

Symptom indexes to assess outcomes of treatment for early prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11117.X

Measuring patients' perceptions of the outcomes of treatment for early prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11117.X

Intensity-modulated radiotherapy as primary treatment for prostate cancer: acute toxicity in 114 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11117.X

Individualizing quality-of-life outcomes reporting: how localized prostate cancer treatments affect patients with different levels of baseline urinary, bowel, and sexual function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11117.X

Longitudinal analysis of quality of life in patients receiving conformal radiation therapy for prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11117.X

Consequential late effects after radiotherapy for prostate cancer - a prospective longitudinal quality of life study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11117.X

Bringing Prostate Cancer Quality of Life Research Back to the Bedside: Translating Numbers Into a Format That Patients can Understand

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11117.X

Intensity-modulated Radiotherapy Allows Escalation of the Radiation Dose to the Pelvic Lymph Nodes in Patients with Locally Advanced Prostate Cancer: Preliminary Results of a Phase I Dose Escalation Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11117.X

10.1111/J.1464-410X.2012.11117.X

21 January 2018

Identifiers

DOI

1 reference

27 November 2017

1 reference